BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 27600294)

  • 21. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
    Hingorani P; Zhang W; Gorlick R; Kolb EA
    Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fisetin Suppresses Human Osteosarcoma U-2 OS Cell Migration and Invasion
    Chen JK; Peng SF; Lai KC; Liu HC; Huang YP; Lin CC; Huang AC; Chueh FS; Chung JG
    In Vivo; 2019; 33(3):801-810. PubMed ID: 31028200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling.
    Jiang WG; Ye L; Ji K; Ruge F; Wu Y; Gao Y; Ji J; Mason MD
    Oncol Rep; 2013 Sep; 30(3):1405-13. PubMed ID: 23828123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
    Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
    Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
    Pan PJ; Tsai JJ; Liu YC
    Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways.
    Son J; Lee SY
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22868. PubMed ID: 34338395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal adhesion kinase signaling is necessary for the Cyclosporin A-enhanced migration and invasion of human trophoblast cells.
    Tang CL; Zhao HB; Li MQ; Du MR; Meng YH; Li DJ
    Placenta; 2012 Sep; 33(9):704-11. PubMed ID: 22766276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.
    Chiu KY; Wu CC; Chia CH; Hsu SL; Tzeng YM
    Cancer Lett; 2016 Apr; 373(2):174-84. PubMed ID: 26679052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
    Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner.
    Wang QL; Wang L; Li QY; Li HY; Lin L; Wei D; Xu JY; Luo XJ
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4447-4459. PubMed ID: 38108838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway.
    Yue B; Ren QX; Su T; Wang LN; Zhang L
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2640-7. PubMed ID: 25317798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition.
    Chen PN; Yang SF; Yu CC; Lin CY; Huang SH; Chu SC; Hsieh YS
    Environ Toxicol; 2017 Aug; 32(8):2053-2063. PubMed ID: 28371048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of RhoA and its effectors ROCK and mDia1 in the modulation of deformation-induced FAK, ERK, p38, and MLC motogenic signals in human Caco-2 intestinal epithelial cells.
    Chaturvedi LS; Marsh HM; Basson MD
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1224-38. PubMed ID: 21849669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
    Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
    Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells.
    Kimura R; Ishikawa C; Rokkaku T; Janknecht R; Mori N
    Biochim Biophys Acta; 2011 Aug; 1813(8):1543-53. PubMed ID: 21640141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways.
    Chang PY; Hsieh MJ; Hsieh YS; Chen PN; Yang JS; Lo FC; Yang SF; Lu KH
    Environ Toxicol; 2017 Aug; 32(8):2032-2040. PubMed ID: 27860196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.
    Chua KN; Kong LR; Sim WJ; Ng HC; Ong WR; Thiery JP; Huynh H; Goh BC
    Oncotarget; 2015 Oct; 6(30):29991-30005. PubMed ID: 26358373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.